Search Results - "MATSUTANI, Masao"

Refine Results
  1. 1

    Consensus on the management of intracranial germ-cell tumours by Murray, Matthew J, PhD, Bartels, Ute, MD, Nishikawa, Ryo, Prof, Fangusaro, Jason, MD, Matsutani, Masao, Prof, Nicholson, James C, Dr

    Published in The lancet oncology (01-09-2015)
    “…Summary The management of intracranial germ-cell tumours is complex because of varied clinical presentations, tumour sites, treatments and outcomes, and the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Histopathology and prognosis of germ cell tumors metastatic to brain: cohort study by Takami, Hirokazu, Graffeo, Christopher S., Perry, Avital, Ohno, Makoto, Ishida, Joji, Giannini, Caterina, Narita, Yoshitaka, Nakazato, Yoichi, Saito, Nobuhito, Nishikawa, Ryo, Matsutani, Masao, Ichimura, Koichi, Daniels, David J.

    Published in Journal of neuro-oncology (01-08-2021)
    “…Introduction Germ cell tumors (GCTs) are uncommon neoplasms predominantly arising in midline tissues. The prognostic significance of histopathology in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Current Status of Palliative and Terminal Care for Patients with Primary Malignant Brain Tumors in Japan by AOKI, Tomokazu, NARITA, Yoshitaka, MISHIMA, Kazuhiko, MATSUTANI, Masao

    Published in Neurologia medico-chirurgica (01-01-2020)
    “…Palliative care and advance care planning (ACP) from the first diagnosis of glioblastoma are important. This questionnaire survey was conducted to understand…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression by Mishima, Kazuhiko, Kato, Yukinari, Kaneko, Mika Kato, Nishikawa, Ryo, Hirose, Takanori, Matsutani, Masao

    Published in Acta neuropathologica (01-05-2006)
    “…Podoplanin (aggrus) is a mucin-like transmembrane sialoglycoprotein that is expressed on lymphatic endothelial cells. Podoplanin is putatively involved in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma by Nagane, Motoo, Nishikawa, Ryo, Narita, Yoshitaka, Kobayashi, Hiroyuki, Takano, Shingo, Shinoura, Nobusada, Aoki, Tomokazu, Sugiyama, Kazuhiko, Kuratsu, Junichi, Muragaki, Yoshihiro, Sawamura, Yutaka, Matsutani, Masao

    Published in Japanese journal of clinical oncology (01-10-2012)
    “…This single-arm, open-label, Phase II study evaluated the efficacy and safety of single-agent bevacizumab, a monoclonal antibody against vascular endothelial…”
    Get full text
    Journal Article
  12. 12

    Clinical management of primary central nervous system germ cell tumors by Matsutani, Masao

    Published in Seminars in oncology (01-10-2004)
    “…Despite excellent long-term results for patients with germinoma treated with radiation therapy, the potential for late effects makes the treatment…”
    Get full text
    Journal Article
  13. 13

    Duration between onset and diagnosis in central nervous system tumors: Impact on prognosis and functional outcome by Fukuoka, Kohei, Yanagisawa, Takaaki, Suzuki, Tomonari, Shirahata, Mitsuaki, Adachi, Jun-ichi, Mishima, Kazuhiko, Fujimaki, Takamitsu, Matsutani, Masao, Nishikawa, Ryo

    Published in Pediatrics international (01-12-2014)
    “…Background The initial presentation of central nervous system (CNS) tumors in children frequently mimics other more common and less serious conditions,…”
    Get full text
    Journal Article
  14. 14

    Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma by Suzuki, Tomonari, Wada, Satoru, Eguchi, Hidetaka, Adachi, Jun-ichi, Mishima, Kazuhiko, Matsutani, Masao, Nishikawa, Ryo, Nishiyama, Masahiko

    Published in Journal of neurosurgery (01-11-2013)
    “…Gliomas contain aggressive malignant cancer, and resection rate remains an important factor in treatment. Currently, fluorescence-guided resection using orally…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma by Mishima, Kazuhiko, Kato, Yukinari, Kaneko, Mika K, Nakazawa, Youya, Kunita, Akiko, Fujita, Naoya, Tsuruo, Takashi, Nishikawa, Ryo, Hirose, Takanori, Matsutani, Masao

    Published in Acta neuropathologica (01-06-2006)
    “…Podoplanin, a mucin-like transmembrane sialoglycoprotein, promotes platelet aggregation and may be involved in cancer cell migration, invasion, metastasis, and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report by Mukasa, Akitake, Yanagisawa, Shunsuke, Saito, Kuniaki, Tanaka, Shota, Takai, Keisuke, Shibahara, Junji, Ikegami, Masachika, Nakao, Yusuke, Takeshita, Katsushi, Matsutani, Masao, Saito, Nobuhito

    Published in Journal of neurosurgery. Spine (01-03-2017)
    “…Primary spinal germ cell tumors are rare, and spinal nongerminomatous germ cell tumors represent an even rarer subset for which no standard therapy has been…”
    Get full text
    Journal Article
  19. 19
  20. 20